1Ernst E,Hammerschmidt DE,Bagge U,et al.Leukocyte and the risk of ischemic heart disease.JAMA,1987,257 (17):2318-2324.
2Furman MI,Becker RC,Yarzebski J,et al.Effect of elevated leukocyte count on in hospital mortality following acute myocardial infarction.Am JCardiol.1996,78 (8):945-948.
3Prentice RL,Szatrowski TP,Fujikura T,et al.Leukocyte counts and coronary heart disease in a Japanese cohort.Am Epidemiol,1982,116 (3):496.
4Braunuward E.on future directions for cardiology.Circulation,1998,77 (1):13.
5Zeiher AM,Wollschlaeger H,Bonzel T,et al.Hierarchy of levels of ischemia-indced impairment in regional left ventricular systolic function in man.Circulation,1987,76 (4):768.
8BarbaraRossi,Stefano Angiari,Elena Zenaro.et al.Vascular inflammation incentral nervous system diseaseiadhesion receptors controllingleukocyte-endothelial interactions.Joumal of Leukocyte Biology ,2011,89 (4):539-556.
9TullioPalmerini, Roxana Mehran, George Dangas, et al. Impact of LeukocyteCount on Mortality and Bleeding in Patients With Myocardial InferctionUndergoing Primary Percutaneous Coronary Interventions: Analysis From theHarmonizing Outcome With Revascularization and Stent in Acute MyocardialInfarction Trial.Circulation.2011,123:2829-2837.
10GurmHS, Bhatt DL, Lincoff AM, Tcheng JE,Kereiakes DJ,Kleiman NS,Jia G,Topol EJ. Impact of preprocedural white blood cell count on long termmortality after percutaneous coronary intervention:insights from the EPIC,EPILOG,and EPISTENT trials.Heart.2003;89(10):1200-1204.
